Table 1.
Sociodemographic and clinical characteristics of the study population (N = 300)
| Variable | Frequency (N = 300) | Percentage (%) |
|---|---|---|
| Sex | ||
| Males | 80 | 26.7 |
| Females | 220 | 73.3 |
| Age (years) | ||
| 21–30 | 44 | 14.7 |
| 31–40 | 115 | 38.3 |
| 41–50 | 95 | 31.7 |
| 51–60 | 37 | 12.3 |
| 61–70 | 6 | 2.0 |
| 71–80 | 3 | 1.0 |
| Marital status | ||
| Married | 140 | 46.7 |
| Widowed | 91 | 30.3 |
| Single | 38 | 12.7 |
| Divorce | 6 | 2 |
| Cohabitate | 25 | 8.3 |
| Educational status | ||
| None | 19 | 6.3 |
| Primary | 158 | 52.7 |
| Secondary | 68 | 22.7 |
| High school | 30 | 10 |
| University | 25 | 8.3 |
| Occupational status | ||
| Employed | 234 | 78 |
| Unemployed | 50 | 16.7 |
| Retired | 16 | 5.3 |
| Funding sources | ||
| Self | 196 | 65.3 |
| Non-self | 104 | 34.7 |
| Living companion | ||
| No | 56 | 18.7 |
| Yes | 244 | 81.3 |
| Alcohol consumption | ||
| No | 280 | 93.3 |
| Yes | 20 | 6.7 |
| Smoking | ||
| No | 293 | 97.7 |
| Yes | 7 | 2.3 |
| Duration from diagnosis of HIV infection (months) | ||
| ≤23 | 79 | 26.3 |
| 24–59 | 110 | 36.7 |
| ≥60 | 111 | 37 |
| Duration on HAART treatment (months) | ||
| ≤23 | 84 | 27.8 |
| 24–59 | 105 | 35.1 |
| ≥60 | 111 | 37.1 |
| CD4 + count cells/µl | ||
| 0–50 | 5 | 1.7 |
| 51–200 | 18 | 5.7 |
| 201–350 | 95 | 31.8 |
| >350 | 182 | 60.8 |
| ARV combinations | ||
| TLE | 194 | 64.3 |
| ZLN | 69 | 23.0 |
| TLLI | 20 | 6.7 |
| TLN | 17 | 6.0 |
TLE tenofovir, lamivudine, efavirenz; ZLN zidovudine, lamivudine, nevirapine; TLN tenofovir, lamivudine, nevirapine; TLLI tenofovir, lamivudine, lopinavir, indinavir